Zydus Cadila gets FDA nod for generic LetairisAmbrisentan tablets had a market value of $943 million in 2018. How pharmacist prescribing in the U.K. can inform American effortsIn the U.K., there are basic levels of pharmacy classification, defined services, training and supervision required, as well as some significant price controls and limits to the overall system. Zydus launches generic Cialis Tadalafil tablets had a market value of $1.73 billion, according to January 2019 IQVIA data. FDA clears Clarus Therapeutics' Jatenzo Jatenzo's oral route of administration provides a new treatment option for men with certain hypogonadal conditions. CBD who’s who: CBD Unlimited CBD Unlimited offers specific delivery methods: topical mist and balm, as well as tinctures and adaptogen herbal capsules, which include a nighttime formulation. Lupin gets FDA nod for generic Cialis Cialis had a market value of about $1.7 billion, according to December 2018 IQVIA data. NACDS commends Kentucky e-prescribing law Sixty-two percent of Kentucky voters support an e-prescribing requirement as an opioid fraud and abuse prevention strategy. Lupin launches generic Synthroid Levothyroxine sodium tablets had a market value of roughly $2.5 billion, according to January 2019 IQVIA data. FDA clears Lupin’s generic Viagra The erectile dysfunction treatment had a market value of $611 million, according to December 2018 IQVIA data. U.S. News & World Report, Aetna Foundation release 2019 healthiest communities rankings The second annual list helps identify best practices and accelerate progress for community health across the country. First Previous 12 13 14 15 16 Next Last
